Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 34,818,304	$ 40,912,575
Restricted cash	100,000	100,000
Prepaid expenses and other current assets	702,546	989,865
Total current assets	35,620,850	42,002,440
Equipment, net	9,524	10,884
Capitalized software, net	10,642	17,027
Goodwill	14,869,399	14,869,399
Total assets	50,510,415	56,899,750
Current liabilities
Accounts payable	1,435,568	1,805,320
Accrued expenses and other current liabilities	1,395,227	1,535,097
Total current liabilities	2,830,795	3,340,417
Liability related to the sale of future royalties	84,267,066	82,016,823
Total liabilities	87,097,861	85,357,240
Commitments and contingencies (Note 8)
Stockholders' deficit
Preferred stock; $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of March 31, 2024 and December 31, 2023
Common stock; $0.0001 par value; 125,000,000 shares authorized; 6,993,406 shares issued and outstanding as of March 31, 2024 and December 31, 2023	699	699
Additional paid-in capital	368,796,088	368,357,239
Accumulated deficit	(405,384,233)	(396,815,428)
Total stockholders' deficit	(36,587,446)	(28,457,490)
Total liabilities and stockholders' deficit	$ 50,510,415	$ 56,899,750